TRUALT · NSE,BSE · Other Agricultural Products
Trualt Bioenergy IPO listed on 03 Oct 2025 on NSE,BSE at ₹545.40, a gain of 9.96% over the issue price of ₹496.00. The IPO was subscribed 71.92x overall.
Trualt Bioenergy IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 25 Sep 2025 |
| IPO Close Date | 29 Sep 2025 |
| Basis of Allotment | 30 Sep 2025 |
| Initiation of Refunds | 01 Oct 2025 |
| Credit of Shares to Demat | 01 Oct 2025 |
| Listing Date | 03 Oct 2025 |
Listing day gain
+9.96%
Listed at ₹545.4 (issue ₹496)
Issue
₹496
Listing
₹545.4
Current
₹530.95
+7.05% vs issue
Day range
₹512.8 – ₹549
Issue Size
16,920,967 shares
(aggregating up to ₹839.28 Cr)
Issue Price
₹472 – ₹496
Face Value
₹10/share
Market Lot
30 shares
Retail Min Investment
₹14,880
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
15,120,967 shares
(aggregating up to ₹750 Cr)
Offer for Sale
1,800,000 shares
(aggregating up to ₹89.28 Cr)
Issue Type
book building
Open Date
25 Sep
Close Date
29 Sep
Allotment
30 Sep
Listing
03 Oct
Last updated: 1 year ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 03 Oct 2025 Latest | ₹496 | ₹85 | ₹581 | ₹85 |
17.14%
|
12:00 AM |
| 02 Oct 2025 | ₹496 | ₹90 | ₹586 | ₹90 |
18.15%
|
12:00 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 03 Oct 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 159.22x |
| NII | 98.56x |
| bNII (bids above ₹10L) | 113.46x |
| sNII (bids below ₹10L) | 68.76x |
| Retail Investors | 11x |
| Total | 71.92x |
Showing the latest subscription snapshot.
View full subscription historyVijaykumar Murugesh Nirani, Vishal Nirani and Sushmitha Vijaykumar Nirani
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹14,880 |
| Retail (Max) | 13 | 390 | ₹193,440 |
| S-HNI (Min) | 14 | 420 | ₹208,320 |
| S-HNI (Max) | 67 | 2,010 | ₹996,960 |
| B-HNI (Min) | 68 | 2,040 | ₹1,011,840 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 8,460,482 (50.00%) |
|
•
Anchor Investor Shares Offered
|
5,076,289 (30.00%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
3,384,193 (20.00%) |
| NII (HNI) Shares Offered | 2,538,146 (15.00%) |
|
•
bNII > ₹10L
|
1,692,098 (10.00%) |
|
•
sNII < ₹10L
|
846,048 (5.00%) |
| Retail Shares Offered | 5,922,339 (35.00%) |
| Total Shares Offered | 16,920,967 (100.00%) |
TruAlt Bioenergy Limited was originally incorporated as TruAlt Energy Limited on March 31, 2021, and was renamed TruAlt Bioenergy Limited on July 1, 2022. It is headquartered in Bagalkot, Karnataka, and works in the biofuel sector, with a primary focus on ethanol production.
The company operates five distillery units in the Bagalkot district of Karnataka, four of which run on molasses and syrup-based feedstocks, with an installed ethanol production capacity of 2,000 kilo litres per day as of March 31, 2025, the largest in India by that measure. It also produces compressed biogas (CBG) through its wholly owned subsidiary, Leafiniti Bioenergy, as part of the Government of India's SATAT initiative. In FY25, 72% of its revenue came from Oil Marketing Companies, and its top 10 customers accounted for 99.78% of total revenue. The company is promoted by Vijaykumar Murugesh Nirani, who serves as Managing Director, along with Sushmitha Vijaykumar Nirani and Vishal Nirani.
Consolidated revenue from operations rose to Rs 1,907.72 crore in FY25 from about Rs 1,273 crore in FY24, while profit after tax rose to about Rs 147 crore in FY25 from about Rs 32 crore in FY24. This was a mainboard IPO, listed on the NSE and BSE, comprising a fresh issue of up to 1,51,20,967 equity shares of face value Rs 10 each aggregating up to Rs 750 crore, along with an offer for sale of up to 18,00,000 equity shares by promoter group sellers Dhraksayani Sangamesh Nirani and Sangamesh Rudrappa Nirani, at an issue price of Rs 496 per share, taking the total issue size to about Rs 839.28 crore. Of the net proceeds, Rs 425 crore was earmarked for funding working capital requirements, with the balance for general corporate purposes.
Standalone · ₹ in Crores
| Particulars | FY Mar 2024 | FY Mar 2025 |
|---|---|---|
| Total Revenue | 1,280.19 | 1,968.53 |
| Profit After Tax (PAT) | 31.81 | 146.64 |
| EBITDA | 188.09 | 309.14 |
| Total Assets | 2,419.08 | 3,029.73 |
| Net Worth | 264.61 | 769 |
| Reserves & Surplus | - | - |
| Total Borrowing | 1,684.68 | 1,549.68 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2025 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 28.27% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 10.88% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 19.07% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 7.69% |
| EBITDA Margin Earnings Before Interest, Tax, Depreciation and Amortisation Margin Profit from the main business as a share of sales, before loan interest and tax. Compare it with other companies in the same industry. | 16.2% |
| Debt / Equity Debt to Equity How much the company has borrowed against what shareholders own. Above 1x means the loans are bigger than shareholder funds. | 2.02x |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 4.56x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹20.76 | ₹17.1 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 23.89x | 29.01x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹3,503 Cr | ₹4,553 Cr |
The basis of allotment for Trualt Bioenergy IPO was finalised on 30 Sep 2025. You can check your allotment status using your PAN number or application number on the Bigshare Services Private Limited portal or BSE.
The Trualt Bioenergy IPO is expected to open in Sep 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Trualt Bioenergy IPO is ₹472.00 - ₹496.00 per share.
As per market sources, Trualt Bioenergy IPO GMP is currently ₹85.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Trualt Bioenergy IPO stands at 71.92x overall.
The listing date for Trualt Bioenergy IPO is 03 Oct 2025.
No comments yet. Be the first to comment!